Flat ₹100 OFF on First app order | Use Code: APP100 |
Flat ₹100 OFF
on First app order
Use Code
APP100
Download Now
100% Same
Salt CompositionEffectivenessStrength
Top Branded
Substitute
Salt Composition in bothMoxifloxacin 400mg
Navimox 400mg Tablet 10 Tablet
You Searched
Navimox 400mg Tablet 10 Tablet
Swastik Life Sciences
₹75
Our Recommendation
Mormox F 400mg Tablet 5s
704+ trust this
WHO GMP Certified
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
Delivery by
Used In
Treatment of Bacterial eye infections
Customers also bought
More About Navimox
Benefits
In Treatment of Bacterial eye infections Navimox 400mg Tablet is an antibiotic medicine. It works by stopping the growth of the bacteria that is causing the infection. It helps relieve symptoms such as pain, redness, itching or soreness caused due to eye infections. The dose and duration of treatment will be decided by your doctor based on your condition. Make sure you complete the full course of treatment. This will ensure that the infection is completely cured and prevent it from returning.
Side Effects
The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you're worried about them.
How to use
Follow your doctor's guidance regarding the dose and duration of this medication. Ingest it without breaking or crushing. Do not chew, crush or break it. Navimox 400mg Tablet can be taken it with or without food, although it's advisable to take it consistently at the same time.
How it works
Navimox 400mg Tablet is an antibiotic. It works by stopping the action of a bacterial enzyme called DNA-gyrase. This prevents the bacterial cells from dividing and repairing, thereby killing them.
Safe: No harmful side effects are associated with consuming alcohol alongside Navimox 400mg Tablet 10 Tablet
Seek medical advice from your doctor: Navimox 400mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Doctor consultation is advised.
Seek medical advice from your doctor: Navimox 400mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Not Safe: Navimox 400mg Tablet may cause side effects which could affect your ability to drive. Navimox 400mg Tablet may make you feel dizzy or light-headed, you may experience a sudden, transient loss of vision, or you may faint for a short period. This may affect your driving ability.
Safe when prescribed by an expert: Navimox 400mg Tablet is safe to use in patients with kidney disease. No dose adjustment of Navimox 400mg Tablet is recommended. However, inform your doctor if you have any underlying kidney disease.
Caution Advised: Navimox 400mg Tablet should be used with caution in patients with severe liver disease. Dose adjustment of Navimox 400mg Tablet may be needed. Doctor consultation is advised. Limited information is available on the use of Navimox 400mg Tablet in these patients. No dose adjustment is recommended in patients with mild to moderate liver disease.
What if I forget to take it?
If a dose of Navimox 400mg Tablet 10 Tablet is missed, take it promptly. However, if your next dose is approaching, skip the missed dose and resume your regular schedule. Avoid doubling the dose.
Manufacturer Address
Plot no. 295, Industrial Area, phase-2, Panchkula (HR)
References
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 940-41
Moxifloxacin. South Oak Way: Bayer Plc; 2003 (01 Apr. 2019)
Moxifloxacin. Wayne, NJ: Bayer HealthCare; 1999 (01 Apr. 2019)
Chaves RG, Lamounier JA. Breastfeeding and maternal medications. J Pediatr (Rio J). 2004;80(5 Suppl):S189-98 (01 Apr. 2019)
Central Drugs Standard Control Organisation (CDSCO) (01 Apr. 2019)
Moxifloxacin Hydrochloride (20 Feb. 2024)
Disclaimer
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
